10x Genomics (TXG) closed at $71.55 on Oct 23, 2026, up 2.6% on the day. The stock is down 14.9% over the past month, up 55.8% over three months, up 338.7% year to date and up 483.6% over the past year. It trades 30.4% below its 52-week high of $102.81 and 479.8% above its 52-week low of $12.34. The close sits below its 50-day moving average ($72.36) and above its 200-day moving average ($39.15).
NextPick tracks TXG in its Genomics basket alongside ILMN, TWST, WGS and PACB. As of Oct 23, 2026, the basket's money-flow score is -27 (weak outflow), and the basket is up 4.1% over five sessions. Over the past month TXG ranks 3rd of 5 basket members by price change.
Form 4 filings over the last 90 days show no open-market purchases and 28 open-market sales by insiders.
Yes — the Oct 23, 2026 close of $71.55 is 82.8% above the 200-day average of $39.15.
TXG closed 30.4% below its 52-week high of $102.81.
NextPick groups TXG with ILMN, TWST, WGS and PACB in its Genomics basket.
10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific. The company offers Chromium platform, a single cell portfolio that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; and QuantumScale single cell RNA and single cell methylation kits. It also provides Visium platform, a spatial analysis platform that uses high density DNA arrays to encode the physical location of biological analytes within a sample. This platform includes HD WT panel gene expression, and HD 3' gene expression assays, as well as the Visium CytAssist, an instrument designed to simplify and optimize the Visium solution workflow by facilitating the transfer of transcriptomic analytes from standard glass slides to Visium slides. In addition, the company offers Xenium Analyzer instrument enables researchers to detect and preserve the cellular location of hundreds of RNA targets directly in a fresh frozen or FFPE tissue section without the need for conventional sequencing; and slides and reagents. Further, it provides various software products comprising Cell Ranger, a scRNA-seq processing pipeline in scientific literature; Loupe Browser, which enables intuitive single-cell, spatial, and multiomic data visualization; and Xenium Explorer that enables intuitive in situ data visualization, which allows researchers to explore subcellular gene expression, spatial organization, and tissue-scale patterns. The company serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
